These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 16506920)

  • 1. Results of a phase II clinical trial on the use of ifosfamide for treatment of cats with vaccine-associated sarcomas.
    Rassnick KM; Rodriguez CO; Khanna C; Rosenberg MP; Kristal O; Chaffin K; Page RL
    Am J Vet Res; 2006 Mar; 67(3):517-23. PubMed ID: 16506920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I trial and pharmacokinetic analysis of ifosfamide in cats with sarcomas.
    Rassnick KM; Moore AS; Northrup NC; Kristal O; Beaulieu BB; Lewis LD; Page RL
    Am J Vet Res; 2006 Mar; 67(3):510-6. PubMed ID: 16506919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of adjuvant single-agent ifosfamide in uterine sarcoma.
    Kushner DM; Webster KD; Belinson JL; Rybicki LA; Kennedy AW; Markman M
    Gynecol Oncol; 2000 Aug; 78(2):221-7. PubMed ID: 10926807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose ifosfamide with mesna and granulocyte-colony-stimulating factor (recombinant human G-CSF) in patients with unresectable malignant mesothelioma.
    Talbot SM; Rankin C; Taub RN; Balcerzak SP; Bhoopalam N; Chapman RA; Baker LH; Middleman EL; Antman KH
    Cancer; 2003 Jul; 98(2):331-6. PubMed ID: 12872353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ifosfamide in the treatment of soft tissue sarcomas.
    Connelly EF; Budd GT
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):16-21. PubMed ID: 8677442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I trial of a 24-h continuous infusion of ifosfamide/mesna in acute lymphoblastic leukemia.
    Otero JC; Solidoro A; Casanova L; Vallejos C; Rodriguez W
    J Exp Ther Oncol; 1996 Mar; 1(2):84-7. PubMed ID: 9414391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-agent ifosfamide in the treatment of anthracycline-refractory adult sarcomas.
    Lopez M; Carpano S; Amodio A; Gionfra T; Della Giulia M; Foggi P; Manfredi C; Del Monte G
    Clin Ter; 1998; 149(5):331-3. PubMed ID: 10052244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lomustine for treatment of mast cell tumors in cats: 38 cases (1999-2005).
    Rassnick KM; Williams LE; Kristal O; Al-Sarraf R; Baez JL; Zwahlen CH; Dank G
    J Am Vet Med Assoc; 2008 Apr; 232(8):1200-5. PubMed ID: 18412534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged 14-day continuous infusion of high-dose ifosfamide with an external portable pump: feasibility and efficacy in refractory pediatric sarcoma.
    Meazza C; Casanova M; Luksch R; Podda M; Favini F; Cefalo G; Massimino M; Ferrari A
    Pediatr Blood Cancer; 2010 Oct; 55(4):617-20. PubMed ID: 20589638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crossover randomized comparison of intravenous versus intravenous/oral mesna in soft tissue sarcoma treated with high-dose ifosfamide.
    Mace JR; Keohan ML; Bernardy H; Junge K; Niebch G; Romeis P; Thoma A; Wagner T; Mueller U; Demetri G; Baker LH
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5829-34. PubMed ID: 14676103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [High-dose ifosfamide in the treatment of patients with soft tissue sarcoma].
    Tiuliandin SA; Liubimova NV; Sidorova NI; Averinova SG; Kashkadaeva AV; Romanova LF; Shiriaev SV; Garin AM
    Vopr Onkol; 1996; 42(6):19-22. PubMed ID: 9123896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of ifosfamide for treatment of various canine neoplasms.
    Rassnick KM; Frimberger AE; Wood CA; Williams LE; Cotter SM; Moore AS
    J Vet Intern Med; 2000; 14(3):271-6. PubMed ID: 10830540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II clinical evaluation of lomustine chemotherapy for feline vaccine-associated sarcoma.
    Saba CF; Vail DM; Thamm DH
    Vet Comp Oncol; 2012 Dec; 10(4):283-91. PubMed ID: 22236148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ongoing clinical studies of ifosfamide for pediatric cancer in the United States.
    Pratt CB
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):84-90. PubMed ID: 8677456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous ifosfamide/mesna is associated with depletion of plasma thiols without depletion of leukocyte glutathione.
    Pendyala L; Creaven PJ; Schwartz G; Meropol NJ; Bolanowska-Higdon W; Zdanowicz J; Murphy M; Perez R
    Clin Cancer Res; 2000 Apr; 6(4):1314-21. PubMed ID: 10778956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-agent ifosfamide studies in sarcomas of soft tissue and bone: the M.D. Anderson experience.
    Benjamin RS; Legha SS; Patel SR; Nicaise C
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S174-9. PubMed ID: 8453693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological changes in bladders of patients submitted to ifosfamide chemotherapy even with mesna prophylaxis.
    Lima MV; Ferreira FV; Macedo FY; de Castro Brito GA; Ribeiro RA
    Cancer Chemother Pharmacol; 2007 Apr; 59(5):643-50. PubMed ID: 16947012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testicular function of survivors of childhood cancer: a comparative study between ifosfamide- and cyclophosphamide-based regimens.
    Ridola V; Fawaz O; Aubier F; Bergeron C; de Vathaire F; Pichon F; Orbach D; Gentet JC; Schmitt C; Dufour C; Oberlin O
    Eur J Cancer; 2009 Mar; 45(5):814-8. PubMed ID: 19216070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study.
    Lorigan P; Verweij J; Papai Z; Rodenhuis S; Le Cesne A; Leahy MG; Radford JA; Van Glabbeke MM; Kirkpatrick A; Hogendoorn PC; Blay JY;
    J Clin Oncol; 2007 Jul; 25(21):3144-50. PubMed ID: 17634494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematologic and systemic toxicoses associated with carboplatin administration in cats.
    Hahn KA; McEntee MF; Daniel GB; Legendre AM; Nolan ML
    Am J Vet Res; 1997 Jun; 58(6):677-9. PubMed ID: 9185979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.